VERNERO, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 1.643
EU - Europa 871
AS - Asia 584
OC - Oceania 45
SA - Sud America 45
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 7
Totale 3.235
Nazione #
US - Stati Uniti d'America 1.563
IT - Italia 269
CN - Cina 213
GB - Regno Unito 117
FR - Francia 94
ES - Italia 86
JP - Giappone 83
IN - India 70
CA - Canada 69
DE - Germania 67
AU - Australia 37
VN - Vietnam 36
IE - Irlanda 31
HK - Hong Kong 29
NL - Olanda 23
PT - Portogallo 22
KR - Corea 20
TR - Turchia 20
IL - Israele 19
PL - Polonia 19
SG - Singapore 19
BR - Brasile 18
KZ - Kazakistan 16
HU - Ungheria 15
CH - Svizzera 14
RO - Romania 13
BE - Belgio 12
FI - Finlandia 12
SE - Svezia 12
CZ - Repubblica Ceca 11
IQ - Iraq 11
IR - Iran 11
DK - Danimarca 10
CO - Colombia 9
EG - Egitto 9
ID - Indonesia 8
MX - Messico 8
NZ - Nuova Zelanda 8
RU - Federazione Russa 8
SA - Arabia Saudita 8
ZA - Sudafrica 8
TW - Taiwan 7
UA - Ucraina 7
AR - Argentina 6
LT - Lituania 6
NO - Norvegia 6
PE - Perù 6
EU - Europa 4
HR - Croazia 4
KE - Kenya 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
LV - Lettonia 3
TG - Togo 3
AP - ???statistics.table.value.countryCode.AP??? 2
AT - Austria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
LU - Lussemburgo 2
MA - Marocco 2
MK - Macedonia 2
NG - Nigeria 2
PK - Pakistan 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
CU - Cuba 1
GE - Georgia 1
IM - Isola di Man 1
KW - Kuwait 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
VE - Venezuela 1
ZM - Zambia 1
Totale 3.235
Città #
Houston 141
Ann Arbor 117
Fairfield 108
Santa Cruz 94
Woodbridge 86
Seattle 60
Ashburn 58
Wilmington 57
Cambridge 46
Buffalo 43
Torino 40
Newbury Park 37
Turin 35
Guangzhou 33
Beijing 32
San Diego 31
Dublin 29
Dong Ket 26
Shanghai 25
London 24
Milan 22
Bengaluru 21
Duncan 18
Ottawa 18
Los Angeles 16
Taldykorgan 16
Toronto 16
Chicago 15
Las Vegas 15
Tokyo 15
Rome 13
Warsaw 13
Boardman 12
Fuzhou 12
Pisa 12
Singapore 12
Amsterdam 11
Córdoba 10
Hangzhou 10
Vigo 10
Central District 9
Mountain View 9
New York 9
Orange 9
Redmond 9
Baghdad 8
Dallas 8
Hyderabad 8
Istanbul 8
Madison 8
Madrid 8
Tianjin 8
Wuhan 8
Jakarta 7
Nanjing 7
Shenyang 7
University Park 7
A Coruña 6
Boulder 6
Budapest 6
Central 6
Changsha 6
Chatsworth 6
Chengdu 6
Copenhagen 6
Debrecen 6
Frankfurt am Main 6
Helsinki 6
Indore 6
Leeds 6
Lisbon 6
Medellín 6
Mumbai 6
Phoenix 6
San Francisco 6
South San Francisco 6
Tel Aviv 6
Toho 6
Barcelona 5
Des Moines 5
Erlanger 5
Henderson 5
Izmir 5
Lake Forest 5
Lappeenranta 5
Liverpool 5
Porto 5
Yongin-si 5
Bologna 4
Clearwater 4
Council Bluffs 4
Hoerby 4
Jinan 4
Kawasaki 4
Khandwa 4
Louisville 4
Manchester 4
Moniga del Garda 4
Naples 4
Paris 4
Totale 1.770
Nome #
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis, file e27ce42d-ffc9-2581-e053-d805fe0acbaa 731
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study, file e27ce42f-4b41-2581-e053-d805fe0acbaa 400
New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series, file e27ce42d-c4ae-2581-e053-d805fe0acbaa 238
P21 | Oral Iron Supplementation with Iron Bisglycinate Chelate in Inflammatory Bowel Disease: A Retrospective Observational Study, file e27ce42e-5579-2581-e053-d805fe0acbaa 207
How ameliorate the adherence in patients with inflammatory bowel disease?, file e27ce42d-594d-2581-e053-d805fe0acbaa 184
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy, file e27ce42d-2549-2581-e053-d805fe0acbaa 177
Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience, file e27ce42e-acc0-2581-e053-d805fe0acbaa 171
OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION, file e27ce42c-ddfa-2581-e053-d805fe0acbaa 165
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets, file e27ce42d-3314-2581-e053-d805fe0acbaa 159
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study, file e27ce433-8ee5-2581-e053-d805fe0acbaa 157
Helicobacter pylori prevalence: Are the data totally reliable?, file e27ce42e-239f-2581-e053-d805fe0acbaa 153
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis, file e27ce431-ffc7-2581-e053-d805fe0acbaa 140
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study, file e27ce430-db6b-2581-e053-d805fe0acbaa 127
Insights into the role of gastrointestinal ultrasound in ulcerative colitis, file e27ce433-4ba7-2581-e053-d805fe0acbaa 75
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study, file e27ce432-4fcf-2581-e053-d805fe0acbaa 68
Inflammatory Bowel Disease Nurse—Practical Messages, file e27ce431-fc45-2581-e053-d805fe0acbaa 63
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease, file e27ce432-4017-2581-e053-d805fe0acbaa 47
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis, file e27ce431-6280-2581-e053-d805fe0acbaa 13
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis, file 8556369a-91e9-4de2-9d85-3378ced85e1f 9
Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis, file 2321af1c-d354-4261-9ae4-843189a97b75 8
Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease, file 3e8037dc-b65e-49e5-b58a-5dc1219b0f7e 8
Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations, file 8993f907-1051-453e-a89b-66349011d36a 8
Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies, file 329632a0-8c90-448b-8fe1-a445bb545e60 5
Periodontitis Prevalence and Severity in Inflammatory Bowel Disease: A Case-Control Study, file f5bcdfa7-5776-4589-9e69-511a79bcf17f 5
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study, file 271df09f-de8f-41c5-bcd6-8399bf1db6fa 4
The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care, file 80ff1113-fa92-4aa8-9d6d-9969454e50ad 4
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease, file 81d0fa7e-fa26-49d3-8760-f42e91f8f68d 4
Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study, file e27ce42e-acbe-2581-e053-d805fe0acbaa 4
Anti-IL23 in inflammatory bowel disease patients with dermatological indication: The shared gastroenterological-dermatological clinic experience, file f4a38ed9-e92d-44b0-8513-05b8e9daed7a 4
Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy, file 215a5f67-55cd-437a-823e-3dc5dd78a15b 3
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease, file 4724d336-9a5b-4ba1-9e28-ed7c43b7d518 3
Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study, file b1d147eb-1eb4-4523-b14d-84e21164442d 3
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves, file d6c7ff70-087b-4c88-a1e0-30ea7a4acd8a 3
Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease, file 3d51b39d-6018-4101-a5ea-dc186e96f5bc 2
Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease, file 544584f5-bc4c-4efe-980d-9e0629f6cc17 2
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons, file a2964754-e047-44e9-8930-df1fabd39752 2
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study, file a3328df2-69a0-4350-961b-567e5ea3aaf4 2
Totale 3.358
Categoria #
all - tutte 5.111
article - articoli 0
book - libri 0
conference - conferenze 512
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201950 0 0 0 0 0 0 0 0 0 0 29 21
2019/2020361 26 10 13 28 12 14 16 54 51 48 49 40
2020/2021810 65 67 58 32 54 137 53 47 79 85 65 68
2021/20221.061 101 50 73 155 114 80 78 63 84 56 145 62
2022/2023784 36 76 149 90 53 76 58 56 90 42 49 9
2023/2024231 22 21 23 11 22 11 41 42 13 19 6 0
Totale 3.358